MTIC
AZN icon

Missouri Trust & Investment Company’s AstraZeneca AZN Stock Holding History

Missouri Trust & Investment Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$19.4K – 165
2026
Q1 		$19.4K Hold
100
– – 0.01% 297
2025
Q4 		$18.4K Hold
100
– – 0.01% 288
2025
Q3 		$15.3K Hold
100
– – ﹤0.01% 305
2025
Q2 		$14K Hold
100
– – ﹤0.01% 300
2025
Q1 		$14.7K Hold
100
– – 0.01% 284
2024
Q4 		$13.1K Hold
100
– – ﹤0.01% 296
2024
Q3 		$15.6K Hold
100
– – 0.01% 272
2024
Q2 		$15.6K Hold
100
– – 0.01% 275
2024
Q1 		$13.6K Hold
100
– – 0.01% 285
2023
Q4 		$13.5K Sell
100
-11
-10% -$1.43K 0.01% 278
2023
Q3 		$15K Hold
111
– – 0.01% 269
2023
Q2 		$15.9K Buy
111
+11
+11% +$1.62K 0.01% 289
2023
Q1 		$13.9K Hold
100
– – 0.01% 244
2022
Q4 		$14K Hold
100
– – 0.01% 233
2022
Q3 		$11K Hold
100
– – 0.01% 246
2022
Q2 		$13K Hold
100
– – 0.01% 254
2022
Q1 		$13K Hold
100
– – 0.01% 260
2021
Q4 		$12K Buy
+100
New +$11.8K 0.01% 283

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Missouri Trust & Investment Company's AZN Position: Q2 2026 in Review

Missouri Trust & Investment Company sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 100 shares — an estimated $19.4K sold.

Missouri Trust & Investment Company first reported a position in AZN in Q4 2021 and held it in 18 quarters. The position peaked at $19.4K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Missouri Trust & Investment Company reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Missouri Trust & Investment Company sold 100 AstraZeneca shares in Q2 2026, an estimated $19.4K.
  • Missouri Trust & Investment Company first reported a position in AstraZeneca in Q4 2021 and held it in 18 quarters.
  • Missouri Trust & Investment Company's AstraZeneca position peaked at $19.4K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q2 2026, filed 13 Aug 2026.